Spore.Bio
The company develops a transformer-based multimodal spectral imaging technology for the rapid detection, quantification, and identification of microorganisms without the need for culture, enrichment, or dyes. Their AI-based hardware is designed for real-time microbial testing to prevent contamination and product recalls. The technology serves industrial quality control across the food, beverage, cosmetics, pharmaceutical, and cell/gene therapy sectors.
Visit websiteParis, France
AI
Microbiology
DeepTech
FoodTech
Biotech
HealthTech
Funding summary
- Total raised
- €30.0M
- Funding rounds
- 3
Investors in Spore.Bio
Investors on record for Spore.Bio. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Spore.Bio?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors